Imbruvica on AARP Medicare Rx Preferred from UHC (S5820-036)
ibrutinib
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 28 per 28 days.
$2,639.52
Patient pays / month, after deductible
$3,100.77
Patient pays / month, before the $615.00 deductible
$7,918.55
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
IMBRUVICA 140 mg Tablet, Film Coated at a preferred retail pharmacy, from the plan's negotiated price of $10,558.06 for a month. Other covered strengths are listed below.
Prior authRequired on all 6 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 6 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| IMBRUVICA 140 mg Capsule | 5 | $2,640.07 | PA · 90 per 30 days |
| IMBRUVICA 140 mg Tablet, Film Coated | 5 | $2,639.52 | PA · 28 per 28 days |
| IMBRUVICA 280 mg Tablet, Film Coated | 5 | $2,639.60 | PA · 28 per 28 days |
| IMBRUVICA 420 mg Tablet, Film Coated | 5 | $2,639.88 | PA · 28 per 28 days |
| IMBRUVICA 70 mg Capsule | 5 | $2,640.07 | PA · 28 per 28 days |
| IMBRUVICA 70 mg/mL Suspension | 5 | $3,527.88 | PA · 240 per 30 days |
Verify with the plan before prescribing or filling. Member services: (877)521-7034. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5820-036